Literature DB >> 11710639

Morphological observations regarding the origins of atypical cystic lobules (low-grade clinging carcinoma of flat type).

F C Koerner1, T Oyama, H Maluf.   

Abstract

This study seeks to define the morphological pathogenesis of a form of cystic transformation of lobules referred to as atypical cystic lobule or low-grade clinging carcinoma of flat type. We collected 25 examples that seem to represent the early stages in the formation of atypical cystic lobules and made a careful study of their morphology. Our observations indicate that this lesion arises from pre-existing, structurally normal terminal duct-lobular units and that it seems to develop by the direct transformation of indigenous luminal cells. The transformed cells first become evident in the small duct or terminal ductule, where they appear as slightly enlarged columnar cells containing atypical nuclei. In more advanced examples, these alterations affect all luminal cells of the terminal duct-lobular unit, but the cells of the terminal ductule continue to show more pronounced changes than the cells lining the acini. The atypical cells within the lobule do not seem to displace the normal acinar cells. Instead, the cells form a continuum, making it impossible to define the point at which atypical cells and normal cells meet. Within the small duct, however, the atypical epithelium comes to an abrupt halt as the duct courses towards the nipple. Considering these observations, we ascribe the formation of atypical cystic lobules to the accumulation of atypical cells in pre-existing terminal duct-lobular units.

Entities:  

Mesh:

Year:  2001        PMID: 11710639     DOI: 10.1007/s004280100426

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  9 in total

1.  Pathological diagnosis of columnar cell lesions of the breast: are there issues of reproducibility?

Authors:  P H Tan; B C-S Ho; S Selvarajan; W M Yap; A Hanby
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

2.  Proliferating activity in columnar cell lesions of the breast.

Authors:  Jean-Christophe Noel; Isabelle Fayt; Sergio Fernandez-Aguilar; Frederic Buxant; Rachel Boutemy
Journal:  Virchows Arch       Date:  2006-10-06       Impact factor: 4.064

Review 3.  Are columnar cell lesions the earliest histologically detectable non-obligate precursor of breast cancer?

Authors:  Gulisa Turashvili; Malcolm Hayes; Blake Gilks; Peter Watson; Samuel Aparicio
Journal:  Virchows Arch       Date:  2008-04-24       Impact factor: 4.064

Review 4.  Preinvasive breast cancer.

Authors:  Dennis C Sgroi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

5.  [Flat epithelial neoplasia and other columnar cell lesions of the breast].

Authors:  F R Fritzsche; M Dietel; G Kristiansen
Journal:  Pathologe       Date:  2006-09       Impact factor: 1.011

6.  Columnar cell lesions and subsequent breast cancer risk: a nested case-control study.

Authors:  Sarah A Aroner; Laura C Collins; Stuart J Schnitt; James L Connolly; Graham A Colditz; Rulla M Tamimi
Journal:  Breast Cancer Res       Date:  2010-08-06       Impact factor: 6.466

7.  Flat epithelial atypia with and without atypical ductal hyperplasia: to re-excise or not. Results of a 5-year prospective study.

Authors:  Ikechukwu Uzoaru; Bradley R Morgan; Zheng G Liu; Frank J Bellafiore; Farah S Gaudier; Jeanne V Lo; Kourosh Pakzad
Journal:  Virchows Arch       Date:  2012-09-08       Impact factor: 4.064

8.  Flat DIN 1 (flat epithelial atypia) on core needle biopsy: 63 cases identified retrospectively among 1,751 core biopsies performed over an 8-year period (1992-1999).

Authors:  Maritza Martel; Patricia Barron-Rodriguez; Idris Tolgay Ocal; Jorge Dotto; Fattaneh A Tavassoli
Journal:  Virchows Arch       Date:  2007-09-05       Impact factor: 4.535

Review 9.  Blunt duct adenosis: a separate entity from columnar cell lesions?

Authors:  Mirthe de Boer; Paul J van Diest
Journal:  J Clin Pathol       Date:  2021-04-15       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.